@article{dda485ec82df4dbc820f818557502139,
title = "Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease",
author = "Eid, {Ryan C.} and Eden Wudneh and Soombal Zahid and Katherine Cahill and Elina Jerschow",
note = "Funding Information: Disclosures: E.J. has research support from Cumberland Pharmaceuticals, Inc and serves on the Advisory Board for Sanofi/Regeneron and Genentech, all unrelated to the present work. K.N. serves on the Advisory Board for Teva, Regeron and Novartis and receives grant support from the National Institutes of Health, all unrelated to the present work. Other authors confirm that there are no known conflicts of interest associated with this publication; no financial support was provided for this work that could have influenced its outcome.",
year = "2020",
month = jan,
doi = "10.1016/j.anai.2019.09.023",
language = "English (US)",
volume = "124",
pages = "102--104",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1",
}